|
|
|
Insider
Information: |
Step Michael D |
Relationship: |
CEO, Director |
City: |
San Diego |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
27,000 |
|
Indirect Shares
|
50,000 |
|
|
Direct
Value |
$11,880 |
|
|
Indirect Value
|
$22,000 |
|
|
Total
Shares |
77,000 |
|
|
Total
Value |
$33,880 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Santarus Inc |
SNTS |
SVP, Corporate Develop... |
2014-01-02 |
0 |
2006-03-16 |
0 |
Premium* |
|
Qualigen Therapeutics Inc |
QLGN |
CEO, Director |
2016-01-07 |
27,000 |
2017-05-11 |
50,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
17 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
SNTS |
Santarus Inc |
SVP, Corporate Development |
|
2006-03-16 |
4 |
B |
$6.50 |
$19,500 |
D/D |
3,000 |
6,331 |
2.74 |
- |
|
SNTS |
Santarus Inc |
SVP, Corporate Development |
|
2011-02-22 |
4 |
D |
$0.00 |
$0 |
D/D |
(13,736) |
19,732 |
0 |
- |
|
SNTS |
Santarus Inc |
SVP, Corporate Development |
|
2013-03-05 |
4 |
OE |
$1.18 |
$10,560 |
D/D |
8,949 |
31,798 |
0 |
- |
|
SNTS |
Santarus Inc |
SVP, Corporate Development |
|
2013-03-05 |
4 |
AS |
$15.45 |
$468,099 |
D/D |
(30,301) |
1,497 |
0 |
- |
|
SNTS |
Santarus Inc |
SVP, Corporate Development |
|
2013-05-06 |
4 |
OE |
$1.18 |
$35,755 |
D/D |
30,301 |
31,798 |
0 |
- |
|
SNTS |
Santarus Inc |
SVP, Corporate Development |
|
2013-05-06 |
4 |
AS |
$18.74 |
$567,701 |
D/D |
(30,301) |
1,497 |
0 |
- |
|
SNTS |
Santarus Inc |
SVP, Corporate Development |
|
2013-07-05 |
4 |
OE |
$1.18 |
$35,755 |
D/D |
30,301 |
31,798 |
0 |
- |
|
SNTS |
Santarus Inc |
SVP, Corporate Development |
|
2013-07-05 |
4 |
AS |
$21.76 |
$659,416 |
D/D |
(30,301) |
1,497 |
0 |
- |
|
SNTS |
Santarus Inc |
SVP, Corporate Development |
|
2013-09-05 |
4 |
AS |
$23.17 |
$702,184 |
D/D |
(30,303) |
1,497 |
0 |
- |
|
SNTS |
Santarus Inc |
SVP, Corporate Development |
|
2013-09-05 |
4 |
OE |
$1.18 |
$35,758 |
D/D |
30,303 |
31,800 |
0 |
- |
|
SNTS |
Santarus Inc |
SVP, Corporate Development |
|
2014-01-02 |
4 |
A |
$1.18 |
$812,759 |
D/D |
155,735 |
157,960 |
0 |
- |
|
SNTS |
Santarus Inc |
SVP, Corporate Development |
|
2014-01-02 |
4 |
D |
$32.00 |
$47,904 |
D/D |
(1,497) |
156,463 |
0 |
- |
|
SNTS |
Santarus Inc |
SVP, Corporate Development |
|
2014-01-02 |
4 |
D |
$32.00 |
$4,983,520 |
D/D |
(155,735) |
728 |
0 |
- |
|
SNTS |
Santarus Inc |
SVP, Corporate Development |
|
2014-01-02 |
4 |
D |
$32.00 |
$23,296 |
D/D |
(728) |
0 |
0 |
- |
|
QLGN |
Qualigen Therapeutics Inc |
CEO |
|
2016-01-07 |
4 |
B |
$1.48 |
$39,960 |
D/D |
27,000 |
27,000 |
2.81 |
- |
|
QLGN |
Qualigen Therapeutics Inc |
CEO |
|
2017-02-27 |
4 |
B |
$2.64 |
$26,480 |
I/I |
10,000 |
37,000 |
2.66 |
- |
|
QLGN |
Qualigen Therapeutics Inc |
CEO |
|
2017-05-11 |
4 |
B |
$0.62 |
$8,007 |
I/I |
13,000 |
50,000 |
2.58 |
- |
|
17 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|